Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African  Children and Infants: Molecular Therapy

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants: Molecular Therapy

4.7
(752)
Write Review
More
$ 15.50
Add to Cart
In stock
Description

Viral Vector Malaria Vaccines Induce High-Level T Cell and

Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West African Children and Infants: Molecular Therapy

Translating the Immunogenicity of Prime-boost Immunization With

Enhancing protective immunity to malaria with a highly immunogenic

Pharmaceuticals, Free Full-Text

Trial Profile After screening for eligibility, parents were

PDF) Safety and Immunogenicity of Heterologous Prime-Boost

LSHTM Research Online

Safety and efficacy of novel malaria vaccine regimens of RTS,S

PDF) Safety and Immunogenicity of ChAd63 and MVA ME-TRAP in West

Safety and efficacy of novel malaria vaccine regimens of RTS,S

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination

/2373928/2/eFigure%201%2

First field efficacy trial of the ChAd63 MVA ME-TRAP vectored

Safety, Immunogenicity and Efficacy of Prime-Boost Vaccination